Mizuho Maintains Buy on Encompass Health, Raises Price Target to $82-Report Released on 8th February 2024
Mizuho Maintains Buy on Encompass Health, Raises Price Target to $82-Report Released on 8th February 2024
瑞穗維持對Encompass Health的買入，將目標股價上調至82美元，報告於2024年2月8日發佈
Mizuho analyst Ann Hynes maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $77 to $82.
瑞穗分析師安·海因斯維持Encomass Health（紐約證券交易所代碼：EHC）的買入並將目標股價從77美元上調至82美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。